European physicians don't like cytoprotective agents?

Journal of Clinical Biochemistry and Nutrition

Volumn 49, Issue 1, 2011, Pages 67-

  Kawai, Takashi ^a   Lanas, Angel ^b   Goto, Shinya ^c  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytoprotective agents

Indexed keywords

ACETYLSALICYLIC ACID; CYTOPROTECTIVE AGENT; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

CELL PROTECTION; HUMAN; LETTER; MEDICAL PRACTICE; MEDICAL SERVICE; PHYSICIAN; SMALL INTESTINE; UPPER GASTROINTESTINAL BLEEDING;

EID: 79959995857     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-140     Document Type: Letter

References (6)

1. Kawai T, Seto Y, Ohkusa T, and et al. The current situation of trans-nasal endoscope and the real condition of upper gastrointestinal injury by NSAIDs (low-dose aspirin). (In Japanese) J New Rem & Clin 2010; 59: 37-39.
2. Lanas A, Polo-Tomas M, Roncales P, and et al. Type of prescription and level of adherence NSAIDs and gastroprotectors in at -risk GI patients. Gastroenterology 2010; 138 Suppl 1: S108 (776).
3. Park SH, Cho CS, Lee OY, and et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled Trial-STORM STUDY. J Clin Biochem Nutr 2007; 40: 148-155.
4. Ono S, Kato M, Imai A, and et al. Preliminary tial of rebamipide for prevention of low-dose aspirin-inducedgastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Biochem Nutr 2009; 45: 248-253.
5. Yamamoto T, Isono A, Mishina Y, and et al. Gatroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. J Clin Biochem Nutr 2010; 47: 27-31.
6. Niwa Y, Nakamura M, Ohmiya N, and et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008; 43: 270-276. (Pubitemid 351650037)